Qiagen NVQGEN
Price$42.04Intrinsic value$44.295% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $44.29median of 6 methods · middle span $42-$53based on filings through 31 Dec 2025
Market Price $42.04Price as of 1 Oct 2026
Margin of Safety +5.4%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 1.2% (near-term consensus, capped) · years 2–5: 7.5%/yr (balance of the path).6.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 67.3%Yr 77.0%Yr 86.8%Yr 96.5%Yr 106.3%
7.5% → 6.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 115.9%Yr 125.6%Yr 135.3%Yr 145.0%Yr 154.6%Yr 164.3%Yr 174.0%Yr 183.7%Yr 193.3%Yr 203.0%
6.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (5/7y) (limited history)9.0%
Discount rate (cost of equity) 8.3%
Volatility vs market (adjusted beta)0.75

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetQiagen NVQGENHealth Care
Valuation
P/E21.7×
P/S4.4×
P/B2.6×
EV / Revenue4.8×
EV / EBITDA—
Profitability
Gross margin62.2%
Operating margin22.3%
Net margin20.3%
FCF margin21.7%
Returns
ROE11.2%
ROA6.8%
ROIC9.2%
Growth
Revenue growth (YoY)5.7%
5-yr fwd EPS growth6.3%
Financial strength
Debt / Equity0.44×
Current ratio3.90×
Altman Z-Score3.6
Interest coverage—
Dividend yield0.8%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.